Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy

Cited by (1,000)

Items 401–500 of 1,000

1. A TLR and Non-TLR Mediated Innate Response to Lentiviruses Restricts Hepatocyte Entry and Can be Ameliorated by Pharmacological Blockade
   Judith Agudo, Albert Ruzo, Kipyegon Kitur, Ravi Sachidanandam, Julie Magarian Blander, Brian D. Brown · 2012 · Molecular Therapy
2. Neurodegeneration and the neuroimmune system
   El Khoury, Joseph · 2010 · Nature Medicine
3. Systemic gene delivery following intravenous administration of AAV9 to fetal and neonatal mice and late-gestation nonhuman primates
   Mattar, Citra N., Wong, Andrew M. S., Hoefer, Klemens, Alonso-Ferrero, Maria E., Buckley, Suzanne M. K., Howe, Steven J., Cooper, Jonathan D., Waddington, Simon N., Chan, Jerry K. Y., Rahim, Ahad A. · 2015 · The FASEB Journal
4. Sialic Acid Deposition Impairs the Utility of AAV9, but Not Peptide-modified AAVs for Brain Gene Therapy in a Mouse Model of Lysosomal Storage Disease
   Yong Hong Chen, Kristin E. Claflin, James C. Geoghegan, Beverly L. Davidson · 2012 · Molecular Therapy
5. Viral vectors for gene therapy and gene modification approaches
   Otto‐Wilhelm Merten, Bruno Gaillet · 2015 · Biochemical Engineering Journal
6. Intracerebroventricular delivery of hematopoietic progenitors results in rapid and robust engraftment of microglia-like cells
   Alessia Capotondo, Rita Milazzo, José Manuel García-Manteiga, Eleonora Cavalca, Annita Montepeloso, Brian S. Garrison, Marco Peviani, Derrick J. Rossi, Alessandra Biffi · 2017 · Science Advances
7. Surface engineering of lentiviral vectors for gene transfer into gene therapy target cells
   Camille Lévy, Els Verhoeyen, François‐Loïc Cosset · 2015 · Current Opinion in Pharmacology
8. Altered glycolipid and glycerophospholipid signaling drive inflammatory cascades in adrenomyeloneuropathy
   Montserrat Ruíz, Mariona Jové, Agatha Schlüter, Carlos Casasnovas, Francesc Villarroya, Cristina Guilera, Francisco J. Ortega, Alba Naudí, Reinald Pamplona, Ramón Gimeno et al. · 2015 · Human Molecular Genetics
9. Bioinformatic Clonality Analysis of Next-Generation Sequencing-Derived Viral Vector Integration Sites
   Anne Arens, Jens-Uwe Appelt, Cynthia C. Bartholomae, Richard Gabriel, Anna Paruzynski, Derek Gustafson, Nathalie Cartier, Patrick R. Aubourg, Annette Deichmann, Hanno Glimm et al. · 2012 · Human Gene Therapy Methods
10. Stem Cell Gene Therapy for Fanconi Anemia: Report from the 1st International Fanconi Anemia Gene Therapy Working Group Meeting
    Jakub Tolar, Jennifer E. Adair, Michael Nicolas Antoniou, Cynthia C. Bartholomae, Pamela Sue Becker, Bruce R. Blazar, Juan Antonio Bueren, Thomas Carroll, Marina Cavazzana, D. Wade Clapp et al. · 2011 · Molecular Therapy
11. Potential Risks to Stable Long-term Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Children With Cerebral X-linked Adrenoleukodystrophy
    Jörn‐Sven Kühl, Jana Kupper, Hermann Baqué, Wolfram Ebell, Jutta Gärtner, Georg Christoph Korenke, Birgit Spors, Ingo Günter Steffen, Gabriele Strauß, Sebastian Voigt et al. · 2018 · JAMA Network Open
12. Lentiviral Vector Production Titer Is Not Limited in HEK293T by Induced Intracellular Innate Immunity
    Carolina B. Ferreira, Rebecca P. Sumner, Maria Teresa Rodriguez-Plata, Jane Rasaiyaah, Richard S. B. Milne, Adrian James Thrasher, Waseem Qasim, Greg J. Towers · 2019 · Molecular Therapy — Methods & Clinical Development
13. The Challenge of Gene Therapy for Neurological Diseases: Strategies and Tools to Achieve Efficient Delivery to the Central Nervous System
    Françoise Piguet, Timothée De Saint-Denis, Emilie Audouard, Kévin Beccaria, Arthur André, Guillaume Wurtz, Raphael Schatz, Sandro Alves, Caroline Sevin, Michel Zérah et al. · 2020 · Human Gene Therapy
14. Therapy Development by Genome Editing of Hematopoietic Stem Cells
    Lola Koniali, Carsten Werner Lederer, Marina Kleanthous · 2021 · Cells
15. Intrathecal Adeno-Associated Viral Vector-Mediated Gene Delivery for Adrenomyeloneuropathy
    Gong, Yi, Berenson, Anna, Laheji, Fiza, Gao, Guangping, Wang, Dan, Ng, Carrie, Volak, Adrienn, Kok, Rene, Kreouzis, Vasileios, Dijkstra, Inge M. et al. · 2019 · Human Gene Therapy
16. HIV-based lentiviral vectors: Origin and sequence differences
    Nathan M. Johnson, Anna Francesca Alvarado, Trey N. Moffatt, Joshua M. Edavettal, Tarun A. Swaminathan, Stephen E. Braun · 2021 · Molecular Therapy — Methods & Clinical Development
17. Rescue of Severe Infantile Hypophosphatasia Mice by AAV-Mediated Sustained Expression of Soluble Alkaline Phosphatase
    Tae Matsumoto, Koichi Miyake, Seiko Yamamoto, Hideo Orimo, Noriko Miyake, Yuko Odagaki, Kumi Adachi, Osamu Iijima, Sonoko Narisawa, José Luís Millán et al. · 2011 · Human Gene Therapy
18. Integration-deficient Lentiviral Vectors Expressing Codon-optimized R338L Human FIX Restore Normal Hemostasis in Hemophilia B Mice
    Thipparat Suwanmanee, Genlin Hu, Tong Gui, Cynthia C. Bartholomae, Ina Kutschera, Christof V. Kalle, Manfred Schmidt, Paul Edward Monahan, Tal Kafri · 2013 · Molecular Therapy
19. Neural stem cells could serve as a therapeutic material for age-related neurodegenerative diseases
    Sarawut Suksuphew · 2015 · World Journal of Stem Cells
20. Gene therapy strategies for hemophilia: benefits versus risks
    Inge Petrus, Marinee Chuah, Thierry VandenDriessche · 2010 · The Journal of Gene Medicine
21. Genotoxicity of retroviral hematopoietic stem cell gene therapy
    Grant D. Trobridge · 2011 · Expert Opinion on Biological Therapy
22. Bone marrow-derived microglia-based neurturin delivery protects against dopaminergic neurodegeneration in a mouse model of Parkinson's disease
    K.C. Biju, Rene A. Santacruz, Cang Chen, Qing Zhou, Jiemin Yao, Sara Rohrabaugh, Robert A. Clark, James L. Roberts, Kimberley A. Phillips, Syed Z. Imam et al. · 2013 · Neuroscience Letters
23. Dissecting Neural Function Using Targeted Genome Engineering Technologies
    Patrick D. Hsu, Feng Zhang · 2012 · ACS Chemical Neuroscience
24. Distinct signaling programs control human hematopoietic stem cell survival and proliferation
    David J. H. F. Knapp, Colin A. Hammond, Nima Aghaeepour, Paul H. Miller, Davide Pellacani, Philip A. Beer, Karen Sachs, Wenlian Qiao, Weijia Wang, R. Keith Humphries et al. · 2016 · Blood
25. Succession of transiently active tumor‐initiating cell clones in human pancreatic cancer xenografts
    Claudia R. Ball, Felix Oppel, Karl Roland Ehrenberg, Taronish D. Dubash, Sebastian M. Dieter, Christopher M. Hoffmann, Ulrich R. Abel, Friederike Herbst, Moritz Koch, Jens Werner et al. · 2017 · EMBO Molecular Medicine
26. GDNF-expressing macrophages mitigate loss of dopamine neurons and improve Parkinsonian symptoms in MitoPark mice
    Cang Chen, Xiuhua Li, Guo Ge, Jingwei Liu, K.C. Biju, Suzette D. Laing, Yusheng Qian, Cori Ballard, Zhixu He, Eliezer Masliah et al. · 2018 · Scientific Reports
27. Elivaldogene Autotemcel: First Approval
    Susan J. Keam · 2021 · Molecular Diagnosis & Therapy
28. Identification of a chronic non‐neurodegenerative microglia activation state in a mouse model of peroxisomal β‐oxidation deficiency
    Verheijden, Simon, Beckers, Lien, Casazza, Andrea, Butovsky, Oleg, Mazzone, Massimiliano, Baes, Myriam · 2015 · Glia
29. Long-Term Follow-Up of Hematopoietic Stem-Cell Gene Therapy for Cerebral Adrenoleukodystrophy
    Bougnères, Pierre, Hacein-Bey-Abina, Salima, Labik, Ivan, Adamsbaum, Catherine, Castaignède, Clémence, Bellesme, Céline, Schmidt, Manfred · 2021 · Human Gene Therapy
30. The human peroxisome in health and disease: The story of an oddity becoming a vital organelle
    Jòseph Vamecq, Mustapha Cherkaoui‐Malki, Pierre Andreoletti, Norbert Latruffe · 2013 · Biochimie
31. Mouse Models of NMNAT1-Leber Congenital Amaurosis (LCA9) Recapitulate Key Features of the Human Disease
    Scott H. Greenwald, Jeremy R. Charette, Magdalena Maria Staniszewska, Lan Ying Shi, Steve D. M. Brown, Lisa V. Stone, Qin Liu, Wanda L. Hicks, Gayle B. Collin, Michael R. Bowl et al. · 2016 · American Journal Of Pathology
32. Aberrant Clonal Hematopoiesis following Lentiviral Vector Transduction of HSPCs in a Rhesus Macaque
    Diego A. Espinoza, Xing Fan, Di Yang, Stefan Cordes, Lauren L. Truitt, Katherine R. Calvo, Idalia M. Yabe, Selami Demirci, Kristin J. Hope, So Gun Hong et al. · 2019 · Molecular Therapy
33. Exploiting Single-Cell Tools in Gene and Cell Therapy
    Daniel Bode, Alyssa H. Cull, Juan A. Rubio-Lara, David G. Kent · 2021 · Frontiers in Immunology
34. Leukodystrophies
    Seth J. Perlman, Soe Mar · 2012 · Advances in experimental medicine and biology
35. Improved analysis of C26:0-lysophosphatidylcholine in dried-blood spots via negative ion mode HPLC-ESI-MS/MS for X-linked adrenoleukodystrophy newborn screening
    Haynes, Christopher A., De Jesús, Víctor R. · 2012 · Clinica Chimica Acta
36. The therapeutic potential of bone marrow‐derived macrophages in neurological diseases
    Kai Zhou, Jinming Han, Yafeng Wang, Yiran Xu, Yaodong Zhang, Changlian Zhu · 2022 · CNS Neuroscience & Therapeutics
37. High-Definition Mapping of Retroviral Integration Sites Defines the Fate of Allogeneic T Cells After Donor Lymphocyte Infusion
    Claudia Cattoglio, Giulietta Maruggi, Cynthia C. Bartholomae, Nirav Malani, Danilo Pellin, Fabienne Cocchiarella, Zulma Irene Magnani, Fabio Ciceri, Alessandro Ambrosi, Christof V. Kalle et al. · 2010 · PLoS ONE
38. Is normal hematopoiesis maintained solely by long-term multipotent stem cells?
    Marina Cavazzana, Alain Fischer, Frederic D. Bushman, Emmanuel Payen, Salima Hacein‐Bey‐Abina, Philippe Leboulch · 2011 · Blood
39. A novel lentiviral vector targets gene transfer into human hematopoietic stem cells in marrow from patients with bone marrow failure syndrome and in vivo in humanized mice
    Cecilia A. Frecha, Caroline Costa, Didier Négre, Fouzia Amirache, Didier Trono, Paula Río, Juan Antonio Bueren, François‐Loïc Cosset, Els Verhoeyen · 2011 · Blood
40. Stem cell-based therapies for HIV/AIDS
    Olivier Pernet, Swati Seth Yadav, Dong Sung An · 2016 · Advanced Drug Delivery Reviews
41. The Landscape of Hematopoietic Stem Cell Transplant and Gene Therapy for X-Linked Adrenoleukodystrophy
    Eric James Mallack, Bela Rui Turk, Helena Yan, Florian Eichler · 2019 · Current Treatment Options in Neurology
42. Gene therapy for Fabry disease: Progress, challenges, and outlooks on gene-editing
    Jakob M. Domm, Sarah K. Wootton, Jeffrey A. Medin, Michael L. West · 2021 · Molecular Genetics and Metabolism
43. Newborn screening for lysosomal storage disorders and other neuronopathic conditions
    Matern, Dietrich, Oglesbee, Devin, Tortorelli, Silvia · 2013 · Developmental Disabilities Research Reviews
44. Advances in Gene Therapy for Fanconi Anemia
    Paula Rı́o, Susana Navarro, Juan Antonio Bueren · 2018 · Human Gene Therapy
45. An overview of development in gene therapeutics in China
    Dawei Wang, Kang Wang, Yujia Cai · 2020 · Gene Therapy
46. Abcd2 Is a Strong Modifier of the Metabolic Impairments in Peritoneal Macrophages of Abcd1-Deficient Mice
    Muneer, Zahid, Wiesinger, Christoph, Voigtländer, Till, Werner, Hauke B., Berger, Johannes, Forss-Petter, Sonja · 2014 · PLoS ONE
47. Efficient gene expression from integration-deficient lentiviral vectors in the spinal cord
    Peluffo, H, Foster, E, Ahmed, S G, Lago, N, Hutson, T H, Moon, L, Yip, P, Wanisch, K, Caraballo-Miralles, V, Olmos, G et al. · 2013 · Gene Therapy
48. Evaluating the Safety of Retroviral Vectors Based on Insertional Oncogene Activation and Blocked Differentiation in Cultured Thymocytes
    Zhou, Sheng, Fatima, Soghra, Ma, Zhijun, Wang, Yong-Dong, Lu, Taihe, Janke, Laura J, Du, Yang, Sorrentino, Brian P · 2016 · Molecular Therapy
49. Delivering genes with human immunodeficiency virus-derived vehicles: still state-of-the-art after 25 years
    Jonas Holst Wolff, Jacob Giehm Mikkelsen · 2022 · Journal of Biomedical Science
50. Optimization of Lentiviral Vectors Generation for Biomedical and Clinical Research Purposes: Contemporary Trends in Technology Development and Applications
    Pankaj Kumar, Woon‐Khiong Chan · 2011 · Current Gene Therapy
51. Lentiviral Vectors for Cancer Immunotherapy and Clinical Applications
    Thérèse Liechtenstein, Noemí Pérez‐Janices, David Escors · 2013 · Cancers
52. Neurodevelopmental Outcome after Hematopoietic Cell Transplantation in Inborn Errors of Metabolism: Current Considerations and Future Perspectives
    Peter M. van Hasselt, Jaap Jan Boelens · 2016 · Neuropediatrics
53. Chitotriosidase as a biomarker of cerebral adrenoleukodystrophy
    Paul J. Orchard, Troy C. Lund, Wes Miller, Steven M. Rothman, Gerald V. Raymond, David R. Nascene, Lisa M. Basso, James C. Cloyd, Jakub Tolar · 2011 · Journal of Neuroinflammation
54. Brain-wide microglia replacement using a nonconditioning strategy ameliorates pathology in mouse models of neurological disorders
    Dadian Chen, Chen Wang, Xi Chen, Jiayu Li, Shuai Chen, Yanzhong Li, Fangling Ma, Tingting Li, Mengling Zou, Xin Li et al. · 2025 · Science Translational Medicine
55. Disease correction by combined neonatal intracranial AAV and systemic lentiviral gene therapy in Sanfilippo Syndrome type B mice
    Coy Don Heldermon, Elizabeth Y. Qin, Kevin K. Ohlemiller, Erik D. Herzog, Jeremy R. Glissen Brown, Carole A. Vogler, Wei Hou, John L. Orrock, Brett E. Crawford, Mark S. Sands · 2013 · Gene Therapy
56. Phosphatidylserine immobilization of lentivirus for localized gene transfer
    Seungjin Shin, Hannah M. Tuinstra, David M. Salvay, Lonnie D. Shea · 2010 · Biomaterials
57. Mucopolysaccharidosis Type III (Sanfilippo Syndrome): Emerging Treatment Strategies
    Jessica de Ruijter, Marlies J. Valstar, Frits A. Wijburg · 2011 · Current Pharmaceutical Biotechnology
58. Safer, Silencing-Resistant Lentiviral Vectors: Optimization of the Ubiquitous Chromatin-Opening Element through Elimination of Aberrant Splicing
    Sean Knight, Fang Zhang, Uta Müller-Kuller, Marieke Bokhoven, Abhinav Gupta, Thomas Broughton, Sha Sha, Michael Nicolas Antoniou, Christian Brendel, Manuel Grez et al. · 2012 · Journal of Virology
59. High-Efficiency Transduction of Primary Human Hematopoietic Stem/Progenitor Cells by AAV6 Vectors: Strategies for Overcoming Donor-Variation and Implications in Genome Editing
    Chen Ling, Kanit Bhukhai, Zifei Yin, Mengqun Tan, Mervin C. Yöder, Philippe Leboulch, Emmanuel Payen, Arun Srivastava · 2016 · Scientific Reports
60. Retroviral Vectors for Cancer Gene Therapy
    Axel Schambach, Michael Alexander Morgan · 2016 · Recent results in cancer research/Recent Results in Cancer Research
61. VISPA2: a scalable pipeline for high-throughput identification and annotation of vector integration sites
    Giulio Spinozzi, Andrea Calabria, Stefano Brasca, Stefano Beretta, Ivan Merelli, Luciano Milanesi, Eugenio Montini · 2017 · BMC Bioinformatics
62. Clinical Trials for Gene Therapy in Lysosomal Diseases With CNS Involvement
    Caroline Sevin, Kumaran Deiva · 2021 · Frontiers in Molecular Biosciences
63. Lentivirus Production Is Influenced by SV40 Large T-Antigen and Chromosomal Integration of the Vector in HEK293 Cells
    Leonor Gama-Norton, Lacramioara Botezatu, Sabrina Herrmann, Matthias Schweizer, Paula M. Alves, H. Häuser, Dagmar Wirth · 2011 · Human Gene Therapy
64. Complexity and network dynamics in physiological adaptation: An integrated view
    György Baffy, Joseph Loscalzo · 2014 · Physiology & Behavior
65. Gene therapy for metabolic diseases
    Randy J. Chandler, Charles P. Venditti · 2016 · Translational Science of Rare Diseases
66. Development of Gene Therapy for Thalassemia
    Nienhuis, A. W., Persons, D. A. · 2012 · Cold Spring Harbor Perspectives in Medicine
67. Heparin-coated superparamagnetic nanoparticle-mediated adeno-associated virus delivery for enhancing cellular transduction
    Jun-Ho Hwang, Slgirim Lee, Eun‐Mi Kim, Jung‐Suk Kim, Chang‐Ha Lee, Ik‐Sung Ahn, Jae‐Hyung Jang · 2011 · International Journal of Pharmaceutics
68. Gene Doping and Sport
    T. Friedmann, O. Rabin, M. Frankel · 2010 · Science
69. Efficient nucleic acid delivery to murine regulatory T cells by gold nanoparticle conjugates
    Lisa Gamrad, Christoph Rehbock, Astrid Maria Westendorf, Jan Buer, Stephan Barcikowski, Wiebke Hansen · 2016 · Scientific Reports
70. Retroviral gene therapy in Germany with a view on previous experience and future perspectives
    Michael Alexander Morgan, Melanie Galla, Manuel Grez, Boris Fehse, Axel Schambach · 2021 · Gene Therapy
71. Patrolling monocytes play a critical role in CX3CR1-mediated neuroprotection during excitotoxicity
    Marc‐André Bellavance, David Gosselin, Voon Wee Yong, Peter K. Stys, Serge Rivest · 2014 · Brain Structure and Function
72. 3D hotspots of recurrent retroviral insertions reveal long-range interactions with cancer genes
    Babaei, Sepideh, Akhtar, Waseem, de Jong, Johann, Reinders, Marcel, de Ridder, Jeroen · 2015 · Nature Communications
73. Long-Term Follow-up of Foamy Viral Vector-Mediated Gene Therapy for Canine Leukocyte Adhesion Deficiency
    Thomas R. Bauer, Laura M. Tuschong, Katherine R. Calvo, Heather R. Shive, Tanya H. Burkholder, Eleanor K Karlsson, Robert R. West, David W Russell, Dennis D. Hickstein · 2013 · Molecular Therapy
74. High-Throughput Genomic Mapping of Vector Integration Sites in Gene Therapy Studies
    Brian C. Beard, Jennifer E. Adair, Grant D. Trobridge, Hans‐Peter Kiem · 2014 · Methods in molecular biology
75. Genetic therapies for sickle cell disease
    Erica B. Esrick, Daniel E. Bauer · 2018 · Seminars in Hematology
76. Persistence of Integrase-Deficient Lentiviral Vectors Correlates with the Induction of STING-Independent CD8+ T Cell Responses
    Céline Cousin, Marine Oberkampf, Tristan Félix, Pierre Rosenbaum, Robert Weil, Sylvie Fabrega, Valeria Morante, Donatella R. M. Negri, Andrea Cara, Gilles Dadaglio et al. · 2019 · Cell Reports
77. Dissociation of Survival, Proliferation, and State Control in Human Hematopoietic Stem Cells
    David J. H. F. Knapp, Colin A. Hammond, Paul H. Miller, Gabrielle M. Rabu, Philip A. Beer, Markéta Řičicová, Véronique Lecault, Daniel Da Costa, Michael A. VanInsberghe, Alice Man Sze Cheung et al. · 2017 · Stem Cell Reports
78. The Leukodystrophies
    Hannah B. Gordon, Anthea Letsou, Joshua L. Bonkowsky · 2014 · Seminars in Neurology
79. Gene therapy for blood diseases
    Kohn, Donald B · 2019 · Current Opinion in Biotechnology
80. Efficient non-viral immune cell engineering using circular single-stranded DNA-mediated genomic integration
    Keqiang Xie, Jakob Starzyk, Ishita Majumdar, Jiao Wang, Katerina Rincones, Thao T.D. Tran, Danna Lee, Sarah Niemi, John Famiglietti, Bernhard Suter et al. · 2024 · Nature Biotechnology
81. Aerosol gene delivery using viral vectors and cationic carriers forin vivolung cancer therapy
    Seong‐Ho Hong, Sung Jin Park, Somin Lee, Chong Su Cho, Myung‐Haing Cho · 2014 · Expert Opinion on Drug Delivery
82. Inhibitory effect of Survivin promoter‐regulated oncolytic adenovirus carrying P53 gene against gallbladder cancer
    Chen Liu, Bin Sun, Ni An, Weifeng Tan, Lu Cao, Xiangji Luo, Yong Yu, Feiling Feng, Bin Li, Mengchao Wu et al. · 2011 · Molecular Oncology
83. Genetic Modification of the Lung Directed Toward Treatment of Human Disease
    Sondhi, Dolan, Stiles, Katie M., De, Bishnu P., Crystal, Ronald G. · 2017 · Human Gene Therapy
84. Hemoglobin disorders: lentiviral gene therapy in the starting blocks to enter clinical practice
    Karine Sii-Felice, Marie Giorgi, Philippe Leboulch, Emmanuel Payen · 2018 · Experimental Hematology
85. UM171 Enhances Lentiviral Gene Transfer and Recovery of Primitive Human Hematopoietic Cells
    Mor Ngom, Suzan Imren, Tobias Maetzig, Jennifer E. Adair, David J. H. F. Knapp, Jalila Chagraoui, Iman Fares, Marie-Ève Bordeleau, Guy Sauvageau, Philippe Leboulch et al. · 2018 · Molecular Therapy — Methods & Clinical Development
86. Successful donor engraftment and repair of the blood-brain barrier in cerebral adrenoleukodystrophy.
    P. Orchard, D. Nascene, Weston P. Miller, Ashish O. Gupta, Daniel L. Kenney-Jung, Troy C. Lund · 2019 · Blood
87. Cellular Innate Immunity and Restriction of Viral Infection: Implications for Lentiviral Gene Therapy in Human Hematopoietic Cells
    Anna Kajaste‐Rudnitski, Luigi Naldini · 2015 · Human Gene Therapy
88. Cell-Based Therapy Manufacturing in Stirred Suspension Bioreactor: Thoughts for cGMP Compliance
    Suman Chandra Nath, Lane Harper, Derrick E. Rancourt · 2020 · Frontiers in Bioengineering and Biotechnology
89. Development of B-lineage predominant lentiviral vectors for use in genetic therapies for B cell disorders.
    Blythe Sather, B. Ryu, B. Stirling, M. Garibov, Hannah M M Kerns, S. Humblet-Baron, A. Astrakhan, D. Rawlings · 2011 · Molecular Therapy
90. Mitochondrial Dysfunction in Demyelinating Diseases
    Karen S. Carvalho · 2013 · Seminars in Pediatric Neurology
91. Dynamic roles of angiopoietin-like proteins 1, 2, 3, 4, 6 and 7 in the survival and enhancement of ex vivo expansion of bone-marrow hematopoietic stem cells
    Shahina Akhter, Md. Mashiar Rahman, Hyun Seo Lee, Hyeon‐Jin Kim, Seong‐Tshool Hong · 2013 · Protein & Cell
92. Mechanisms of blood homeostasis: lineage tracking and a neutral model of cell populations in rhesus macaques
    Sidhartha Goyal, Sanggu Kim, Irvin S. Y. Chen, Tom Chou · 2015 · BMC Biology
93. Use of Heterologous Vesiculovirus G Proteins Circumvents the Humoral Anti-envelope Immunity in Lentivector-Based In Vivo Gene Delivery
    Altar M. Munis, Giada Mattiuzzo, Emma M. Bentley, Mary K. Collins, James E. Eyles, Yasuhiro Takeuchi · 2019 · Molecular Therapy — Nucleic Acids
94. Gene-Based Approaches to Inherited Neurometabolic Diseases
    Valentina Poletti, Alessandra Biffi · 2019 · Human Gene Therapy
95. Lentiviral Hematopoietic Stem Cell Gene Therapy Corrects Murine Pompe Disease
    Merel Stok, Helen de Boer, Marshall W. Huston, Edwin H. Jacobs, Onno Roovers, Trudi P. Visser, Holger Jahr, Dirk Jan Duncker, Elza Dianne van Deel, Arnold J.J. Reuser et al. · 2020 · Molecular Therapy — Methods & Clinical Development
96. Saturated very long-chain fatty acids regulate macrophage plasticity and invasiveness
    Bettina Zierfuss, Agnieszka Buda, Andrea Villoria-González, Maxime Logist, Jure Fabjan, Patricia Parzer, Claire Battin, Streggi Vandersteene, Inge M. E. Dijkstra, Petra Waidhofer‐Söllner et al. · 2022 · Journal of Neuroinflammation
97. The Committee for Advanced Therapies' of the European Medicines Agency Reflection Paper on Management of Clinical Risks Deriving from Insertional Mutagenesis
    Alessandro Aiuti, Giulio Cossu, Pablo de Felipe, María Cristina Galli, Gopalan Narayanan, Matthias Renner, Axel Stahlbom, Christian K. Schneider, Caroline Voltz-Girolt · 2013 · Human Gene Therapy Clinical Development
98. Biomimetic cell stimulation with a graphene oxide antigen-presenting platform for developing T cell-based therapies
    Enbo Zhu, Jiaji Yu, Yan-Ruide Li, Feiyang Ma, Yu-Chen Wang, Yang Liu, Miao Li, Yu Jeong Kim, Yichen Zhu, Zoe Hahn et al. · 2024 · Nature Nanotechnology
99. Production of Non Viral DNA Vectors
    Martin Schleef, Markus Blaesen, Marco Schmeer, Ruth Baier, Corinne Marie, George Dickson, Daniel Scherman · 2010 · Current Gene Therapy
100. The neuronal ceroid lipofuscinoses: Opportunities from model systems
     Kiterie M. E. Faller, Rodrigo Gutierrez‐Quintana, Alamin Mohammed, Ahad A. Rahim, Richard I. Tuxworth, Kim Wager, Michael Bond · 2015 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease